IVBIY News and Press, Innovent Biologics Inc ADR

2026-03-06 06:05:00 ET Listen below or on the go via Apple Podcasts and Spotify U.S. issues 30 day waiver (1:00) and considers requiring permits for global AI chip sales (2:45) China approves Pfizer’s GLP-1 (4:00)... Read the full article on Seeking Alph...

2026-03-06 02:27:55 ET More on Pfizer Pfizer: Obesity Hype And Vaccine Policy Shocks Pfizer's Portfolio Renewal In Progress - High Yields For The Patient Pfizer's Quiet Cash Comeback Pfizer-backed Priovant wins FDA priority review for lead asset FDA r...

2026-02-08 10:33:49 ET More on Eli Lilly, Innovent Biologics Eli Lilly: Positives Outweigh The Concerns Eli Lilly and Company 2025 Q4 - Results - Earnings Call Presentation Eli Lilly and Company (LLY) Q4 2025 Earnings Call Transcript President Trump unveils T...

Innovent Announces IBI3003 (GPRC5D/BCMA/CD3 Trispecific Antibody) Receives Fast Track Designation from the U.S. FDA for Relapsed or Refractory Multiple Myeloma PR Newswire SAN FRANCISCO and SUZHOU, China , Jan. 26, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innove...

Innovent's Partner Ollin Biosciences Announces Positive Topline Data with Superior Outcomes from a Randomized Head-to-Head Study of IBI324 Compared to Faricimab (Vabysmo®) in Diabetic Macular Edema and Wet Age-Related Macular Degeneration PR Newswire SAN FRANCISCO and S...

2026-01-05 09:53:52 ET On November 25, my first coverage of Novo Nordisk A/S ( NVO ) was published on Seeking Alpha. Responding to recent news that its long-shot potential Alzheimer’s indication for Wegovy did not materialize as hoped, I nevertheless initiated coverag...

2026-01-04 09:05:29 ET More on The Health Care Select Sector SPDR® Fund ETF Where To Find Outperformance In 2026 My S&P 500 Prediction On Sector Outperformers And Laggards In 2026 XLV: The Simple Case For Overweighting U.S. Health Care Notable health...

2025-12-30 07:43:40 ET More on Eli Lilly, Novo Nordisk Novo Nordisk: The Real Comeback Starts Now With The Wegovy Pill Eli Lilly: Mr. Market Finally Woke Up, But I'm Not Out Yet (Rating Downgrade) Eli Lilly: Short-Term Upside Exhausted (Rating Downgrade) CMS ...

China's First Domestic Anti-CTLA-4 Monoclonal Antibody, Innovent's TABOSUN® (Ipilimumab N01 Injection) Received NMPA Approval PR Newswire TABOSUN ® (ipilimumab N01 injection) has been approved in combination with TYVYT ® (sintilimab injection) for the neoadjuvant ...

Nature | Two Phase 3 Clinical Results of Mazdutide (GLP-1/GCG Dual Receptor Agonist) in Chinese Adults with Type 2 Diabetes Have Been Back-to-Back Published in Nature PR Newswire SAN FRANCISCO and SUZHOU, China , Dec. 17, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Inno...